Tumor Necrosis Factor Receptor Superfamily Member 18 market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Tumor Necrosis Factor Receptor Superfamily Member 18 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Tumor Necrosis Factor Receptor Superfamily Member 18 market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
AMG-228
BMS-986156
FPA-154
GWN-323
INCAGN-1876
Others
Segment by Application
Melanoma
Non-Small Cell Lung Cancer
Gastric Cancer
Blood Cancer
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Ablynx NV
Amgen Inc
Apogenix GmbH
Bristol-Myers Squibb Company
Five Prime Therapeutics Inc
Incyte Corp
MedImmune LLC
Merck & Co Inc
Novartis AG
OncoMed Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc